Biofrontera Inc. held its Annual Meeting of Stockholders on June 12, 2025. Stockholders elected Heikki Lanckriet as a Class I director of the Company. An amendment to increase the number of authorized shares of common stock from 35,000,000 to 70,000,000 was approved. A proposal to adjourn the meeting to permit further solicitation and vote of proxies was also approved. Additionally, the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.